Products
ENERGY Company aims to become the most reliable service provider in the fields of life sciences and clinical medicine. With advanced technology platforms, it focuses on the development and production of raw materials and reagent kits for cell therapy, gene therapy, and immunodiagnosis, and insists on creating first-class quality scientific research reagents.
Category
With years of expertise in recombinant protein development, Energy provides GMP-grade cytokines characterized by high purity, strong bioactivity, and low endotoxin content. These products support scientific research in cell therapy, drug target identification, and protein structural and functional analysis.
Cell Culture Media
Our chemically defined, serum-free media are independently developed and produced using high-grade raw materials suitable for pharmaceutical or cell culture use. They are designed to support the in vitro culture of immune and stem cells, ensuring high cell viability and functional maintenance.
Cell Culture Kits
Tailored for immunotherapy research, our cell culture kits support the activation and high-yield expansion of NK cells from human peripheral or cord blood, the proliferation and activation of NKT/T cells, and MSC subculture and expansion.
Serum-Free Cryopreservation Solution
This in-house developed cryopreservation solution is optimized for immune cells such as PBMCs and NK cells, ensuring >90% post-thaw viability. It is serum-free, free from xenogeneic components, and chemically defined for maximum safety and consistency.
In Vitro Diagnostic (IVD) Reagents
- Independently developed core technologies
- Flexible cooperation models: raw material supply, technology transfer
- Key antibodies produced in-house
- Custom development available
Antibodies
? Independently developed and manufactured
? High cost-performance ratio; additional discounts for bulk orders
? Recombinant expression technology ensures high purity and batch-to-batch consistency
? Custom antibody production available
Application Areas
Cell Therapy
Immunotherapy
Biological R&D